Rodolphe Thiébaut
Affiliations: | Université de Bordeaux, Talence, Nouvelle-Aquitaine, France |
Google:
"Rodolphe Thiébaut"Parents
Sign in to add mentor| François Dabis | grad student | 2000 | Université de Bordeaux | |
| (Facteurs de risque d'athérosclérose chez les patients infectés par le VIH-1 à l'ère des combinaisons d'antirétroviraux : Cohorte Aquitaine, 1999) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Richert L, Lelièvre JD, Lacabaratz C, et al. (2022) T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial. Journal of Immunology (Baltimore, Md. : 1950) |
| Samri A, Chalouni M, Blanco J, et al. (2020) Influence of the ARV regimen on the early changes in plasma HIV RNA and immune activation at initiation of antiretroviral therapy in naïve HIV-1-infected patients. Journal of Acquired Immune Deficiency Syndromes (1999) |
| Duvignaud A, Lhomme E, Pistone T, et al. (2020) Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial). Trials. 21: 846 |
| Diallo MS, Samri A, Charpentier C, et al. (2020) A comparison of cell activation, exhaustion and expression of HIV co-receptors and restriction factors in HIV-1 and HIV-2 infected Non Progressors. Aids Research and Human Retroviruses |
| Iannetta M, Isnard S, Manuzak J, et al. (2020) Conventional Dendritic Cells and Slan Monocytes During HIV-2 Infection. Frontiers in Immunology. 11: 1658 |
| Capitaine L, Genuer R, Thiébaut R. (2020) Random forests for high-dimensional longitudinal data. Statistical Methods in Medical Research. 962280220946080 |
| Lévy Y, Lacabaratz C, Ellefsen-Lavoie K, et al. (2020) Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial. Plos Pathogens. 16: e1008522 |
| Chalouni M, Rodriguez-Centeno J, Samri A, et al. (2020) Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individuals. Plos One. 15: e0230772 |
| Lhomme E, Hejblum BP, Lacabaratz C, et al. (2019) Analyzing cellular immunogenicity in vaccine clinical trials: a new statistical method including non-specific responses for accurate estimation of vaccine effect. Journal of Immunological Methods. 112711 |
| Larmarange J, Diallo MH, McGrath N, et al. (2019) Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa. Journal of the International Aids Society. 22: e25402 |